IHG
KYTX icon

Insight Holdings Group’s Kyverna Therapeutics KYTX Stock Holding History

Insight Holdings Group’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.54M Hold
989,054
– – 0.6% 17
2025
Q4 		$9.3M Hold
989,054
– – 0.7% 15
2025
Q3 		$5.93M Hold
989,054
– – 0.37% 19
2025
Q2 		$3.04M Hold
989,054
– – 0.13% 28
2025
Q1 		$1.91M Buy
989,054
+76,139
+8% +$225K 0.15% 25
2024
Q4 		$3.41M Hold
912,915
– – 0.22% 23
2024
Q3 		$4.46M Hold
912,915
– – 0.19% 20
2024
Q2 		$6.85M Hold
912,915
– – 0.24% 18
2024
Q1 		$22.7M Buy
+912,915
New +$25.5M 0.63% 15

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Insight Holdings Group's KYTX Position: Q1 2026 in Review

Insight Holdings Group held its Kyverna Therapeutics (KYTX) position steady in Q1 2026 at 989,054 shares worth $8.54M. The position accounts for 0.6% of the portfolio, ranked #17.

Insight Holdings Group first reported a position in KYTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $22.7M in Q1 2024. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Insight Holdings Group held 989,054 shares of Kyverna Therapeutics worth $8.54M as of Q1 2026.
  • Insight Holdings Group left its Kyverna Therapeutics share count unchanged in Q1 2026.
  • Kyverna Therapeutics made up 0.6% of Insight Holdings Group's portfolio in Q1 2026, its #17 holding.
  • Insight Holdings Group first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Insight Holdings Group's Kyverna Therapeutics position peaked at $22.7M in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Insight Holdings Group's 13F filing for Q1 2026, filed 15 May 2026.